157 related articles for article (PubMed ID: 15976726)
1. [News on therapies for uveitis].
de Smet MD
J Fr Ophtalmol; 2005 May; 28(5):556-61. PubMed ID: 15976726
[TBL] [Abstract][Full Text] [Related]
2. TNF inhibition for ophthalmic indications: current status and outlook.
Rifkin LM; Birnbaum AD; Goldstein DA
BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of infliximab, adalimumab and golimumab for non-infectious refractory uveitis in adults.
Borrás-Blasco J; Casterá DE; Cortes X; Abad FJ; Rosique-Robles JD; Mallench LG
Int J Clin Pharmacol Ther; 2015 May; 53(5):377-90. PubMed ID: 25345430
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of children with uveitis treated with infliximab.
Tugal-Tutkun I; Ayranci O; Kasapcopur O; Kir N
J AAPOS; 2008 Dec; 12(6):611-3. PubMed ID: 18930672
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines for the management of uveitis in internal medicine].
Abad S; Sève P; Dhote R; Brézin AP
Rev Med Interne; 2009 Jun; 30(6):492-500. PubMed ID: 18824279
[TBL] [Abstract][Full Text] [Related]
6. Which way forward for treatment of severe ocular inflammation?
Lightman S; McCluskey PJ
Clin Exp Ophthalmol; 2006; 34(4):293-4. PubMed ID: 16764644
[No Abstract] [Full Text] [Related]
7. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
[TBL] [Abstract][Full Text] [Related]
8. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
Suhler EB; Smith JR; Wertheim MS; Lauer AK; Kurz DE; Pickard TD; Rosenbaum JT
Arch Ophthalmol; 2005 Jul; 123(7):903-12. PubMed ID: 16009830
[TBL] [Abstract][Full Text] [Related]
9. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
Demir T; Gödekmerdan A; Balbaba M; Türkçüoglu P; Ilhan F; Demir N
Indian J Ophthalmol; 2006 Dec; 54(4):241-5. PubMed ID: 17090875
[TBL] [Abstract][Full Text] [Related]
10. [TNFalpha inhibitors in the treatment of uveitis].
Greiner K; Plskova J
Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
[TBL] [Abstract][Full Text] [Related]
13. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor-α therapy in uveitis.
Cordero-Coma M; Sobrin L
Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
[TBL] [Abstract][Full Text] [Related]
16. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
Tognon S; Graziani G; Marcolongo R
Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy for ocular diseases.
Jap A; Chee SP
Curr Opin Ophthalmol; 2008 Nov; 19(6):535-40. PubMed ID: 18854699
[TBL] [Abstract][Full Text] [Related]
18. Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up.
Kruh JN; Yang P; Suelves AM; Foster CS
Ophthalmology; 2014 Jan; 121(1):358-364. PubMed ID: 24011995
[TBL] [Abstract][Full Text] [Related]
19. Side-effects of anti-inflammatory therapy in uveitis.
Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
Farvardin M; Afarid M; Mehryar M; Hosseini H
Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
